comscoreResearch News

Research News

Find out what the latest clinical trial results mean for you.
More from this topic
1387 Research news
 
 
Article
Women With Breast Cancer Gene Mutation Have Same or Better Survival as Women Without Mutation

Women with a genetic mutation linked to a higher cancer risk who are diagnosed with breast cancer or ovarian cancer and receive chemotherapy treatment have the same or better survival rates as women who don’t have a genetic mutation linked to higher risk.

 
Article
Chemo Brain Less Likely in Women Who Exercise

Women diagnosed with breast cancer who exercised before, during, and after chemotherapy were less likely to have chemo brain.

Aug 31, 2021 | Diagnosis, Chemotherapy and Exercise
 
Article
Guidelines Help Oncologists Provide Individualized Palliative Care for People Diagnosed With Metastatic Breast Cancer

General oncologists have received new specific, practical recommendations on how to offer individualized palliative care to people diagnosed with metastatic breast cancer.

 
Article
FDA Approves Enhertu for Unresectable or Pretreated Metastatic HER2-Positive Breast Cancer

On Dec. 20, 2019, the U.S. Food and Drug Administration approved Enhertu (chemical name: fam-trastuzumab deruxtecan-nxki) to treat people diagnosed with unresectable HER2-positive breast cancer or metastatic HER2-positive breast cancer that has been treated with two or more anti-HER2 therapies.

Jan 2, 2020 | Diagnosis and Targeted Therapy
 
Article
A New Standard of Care? Enhertu Improves Survival in People With Metastatic HER2-Low Breast Cancer

Compared with doctors’ choice of chemotherapy, Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) improved both progression-free survival and overall survival in people diagnosed with previously treated metastatic HER2-low breast cancer.

 
Article
Breast Cancer Screening Declined Sharply When Pandemic Started

A new study by the Centers for Disease Control and Prevention echoes the results of other studies: Breast cancer screening rates dropped dramatically at the beginning of the COVID-19 pandemic, especially among women of certain racial and ethnic groups.

Jul 23, 2021 | Screening and Testing
 
Article
Experimental Immunotherapy Medicine Works Similarly in Black and White Women With Triple-Negative Breast Cancer

When more Black women diagnosed with early-stage, triple-negative breast cancer joined a study on Imfinzi, the results showed the immunotherapy was as effective in Black women as it was in women of other races and ethnicities.

Aug 5, 2022 | Diagnosis, Ethnicity and Immunotherapy
 
Article
Risk of Heart Problems Lower in Breast Cancer Survivors Who Exercise

Exercise helped reduce the risk of heart problems in women receiving treatment for breast cancer.

 
Article
Hormone-Free Medicine for Hot Flashes Shows Promise

Fezolinetant, an experimental medicine that doesn’t contain hormones, has successfully treated hot flashes.

 
Article
3D Mammograms Reduce Risk of Advanced-Stage Disease in Women With Extremely Dense Breasts and High Risk of Breast Cancer

In women with extremely dense breasts and a high risk of breast cancer, screening with 3D mammograms — rather than 2D digital mammograms — was linked to a lower risk of advanced-stage disease.

 
Article
Black and Hispanic Women May Have Higher Risk of Lymphedema

Among women who had breast cancer surgery and axillary lymph node dissection, Black and Hispanic women were more likely to develop lymphedema than white women, as were women who received chemotherapy before surgery, rather than after surgery.

 
Article
After DCIS, About One in Five Invasive Breast Cancers Unrelated to Original DCIS

In the years following a DCIS (ductal carcinoma in situ) diagnosis, about one in five invasive breast cancers that developed were not related to the original DCIS lesion.

Jun 16, 2022 | Diagnosis
 
Article
Some Older Women With Luminal A Breast Cancer May Be Able To Skip Radiation After Lumpectomy

Women ages 55 and older diagnosed with early-stage, estrogen receptor-positive, progesterone receptor-positive, HER2-negative breast cancer that had low levels of Ki67 protein and a very low risk of recurrence were able to safely skip radiation after lumpectomy.

Jun 16, 2022 | Radiation Therapy and Diagnosis
 
Article
Many Black Metastatic Breast Cancer Patients Never Informed About Clinical Trials

Many Black people diagnosed with metastatic breast cancer never find out about clinical trials from their doctors even though most of them are open to participating in one.

Jun 9, 2022 | Ethnicity and Diagnosis
 
Article
Trodelvy Slightly Improves Progression-Free Survival for Pre-treated Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer

Trodelvy (chemical name: sacituzumab govitecan-hziy) slightly improved progression-free survival in people diagnosed with metastatic hormone receptor-positive, HER2-negative breast cancer previously treated with hormonal therapy, a CDK4/6 inhibitor, and multiple lines of chemotherapy.

Jun 9, 2022 | Targeted Therapy and Diagnosis
 
Article
Lying Facedown for Radiation Therapy Causes Fewer Skin Side Effects in Women With Large Breasts

During external whole-breast radiation therapy for breast cancer, women with large breasts who lay facedown had fewer skin side effects than women who lay faceup.

 
Article
ASCO Issues Guidelines on Exercise, Diet, and Weight Management During Cancer Treatment

Doctors should recommend regular aerobic and resistance exercise for people receiving cancer treatment.

May 26, 2022 | Exercise
 
Article
Breast Cancer Treatment Linked to Increased Risk of Diabetes and High Blood Pressure

Women with a history of invasive breast cancer had a higher risk of developing high blood pressure and diabetes than women without a history of breast cancer.

May 26, 2022 | Diagnosis and Side Effects
 
Article
Infertile Men May Have Much Higher Breast Cancer Risk

Infertility seems to double the risk of breast cancer in men.

 
Article
Chemotherapy, Belly Fat, and Fitness Affect Vaccine Response in Breast Cancer Survivors

Previous chemotherapy treatment, more belly fat, and being less physically fit led to a lower immune response to a typhoid vaccine in women who’d been treated for breast cancer.

May 18, 2022 | Exercise and Chemotherapy
 
Article
Vitamin D, Omega-3s, and Strength Exercises May Reduce Cancer Risk in Older People

Simple at-home strength exercises plus vitamin D and omega-3 supplements seemed to reduce cancer risk in healthy people age 70 and older.

May 12, 2022 | Risk Factors
 
Article
Which Breast Cancer Surgery Offers Better Long-Term Quality of Life?

Women were satisfied with their breasts 10 years after either lumpectomy and radiation or mastectomy and reconstruction for early-stage breast cancer. Still, women who had lumpectomy and radiation had better psychosocial and sexual well-being.

May 6, 2022 | Surgery
 
Article
FDA Approves Enhertu for Unresectable or Metastatic HER2-Low Breast Cancer

On Aug. 5, 2022, the U.S. Food and Drug Administration approved Enhertu to treat unresectable or metastatic HER2-low breast cancer.

Aug 5, 2022
 
Article
Breast Cancer Death Rate Decreases in Florida, but Still Highest for Black Women

Breast cancer death rates decreased among all racial and ethnic groups from 1990 to 2015 in Florida, but Black women were still twice as likely to die from breast cancer as white women.

Jul 8, 2021 | Ethnicity
Showing 24 of 1387